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Abstract
Introduction: Chronic inflammation is a profound systemic modification of the cellular microenvironment which
could affect survival, repair and maintenance of muscle stem cells. The aim of this study was to define the role of
chronic inflammation on the regenerative potential of satellite cells in human muscle.
Methods: As a model for chronic inflammation, 11 patients suffering from rheumatoid arthritis (RA) were included
together with 16 patients with osteoarthritis (OA) as controls. The mean age of both groups was 64 years, with
more females in the RA group compared to the OA group. During elective knee replacement surgery, a muscle
biopsy was taken from the distal musculus vastus medialis. Cell populations from four RA and eight OA patients
were used for extensive phenotyping because these cell populations showed no spontaneous differentiation and
myogenic purity greater than 75% after explantation.
Results: After mononuclear cell explantation, myogenic purity, viability, proliferation index, number of colonies,
myogenic colonies, growth speed, maximum number of population doublings and fusion index were not different
between RA and OA patients. Furthermore, the expression of proteins involved in replicative and stress-induced
premature senescence and apoptosis, including p16, p21, p53, hTERT and cleaved caspase-3, was not different
between RA and OA patients. Mean telomere length was shorter in the RA group compared to the OA group.
Conclusions: In the present study we found evidence that chronic inflammation in RA does not affect the in vitro
regenerative potential of human satellite cells. Identification of mechanisms influencing muscle regeneration by
modulation of its microenvironment may, therefore, be more appropriate.
Introduction
Muscle weakness is a common clinical feature following
injury, in neuromuscular diseases and aging leading to
disability and increased mortality [1-3]. Understanding
cellular mechanisms that regulate loss and gain of mus-
cle mass is, therefore, crucial for treating muscle wast-
ing-associated disorders. The regenerative potential of
skeletal muscle is determined by muscle stem cells,
which are called satellite cells. These are quiescent
mononucleated cells that are sequestered between the
basal lamina and the plasma membrane of the myofibers
[4]. In response to injury, they become activated,
proliferate, differentiate and fuse to existing muscle
fibers or fuse together to form new myofibers during
regeneration of damaged skeletal muscle [5].
Potential explanations for the decline in muscle mass
and strength are multiple factors, including stiffness,
immobility, pain, metabolic, hormonal and nutritional
status [6,7]. These factors could influence muscle regen-
eration indicated by the number of satellite cells and
their proliferative capacity, which in humans is limited
by the mitotic clock [8,9]. Heterochronic parabiosis has
been shown to restore the regenerative potential of aged
satellite cells which suggest that satellite cell activity can
be modulated by the microenvironment and circulating
factors [9]. There is growing evidence that chronic
inflammation can produce a profound systemic modifi-
cation of the cellular microenvironment which could
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[10]. Concentrations of pro-inflammatory cytokines have
been shown to increase with advancing age and result in
a higher catabolic rate and loss of muscle mass [11,12].
The underlying factors influencing the regenerative
potential of satellite cells have not yet been identified.
In the present study, we aimed to define the role of
chronic inflammation on the regenerative potential of
satellite cells in human muscle. As a model for in vivo
c h r o n i ci n f l a m m a t i o n ,w eh a v eu s e dm u s c l eb i o p s i e s
obtained from patients suffering from rheumatoid
arthritis (RA) compared to patients with osteoarthritis
(OA), without signs of chronic inflammation. Patients
with RA have been shown to have a steeper decline in
muscle mass and strength compared to the general
population, which might be due to the chronic inflam-
matory state of these patients [13,14].
Material and methods
Subjects
The total study population included 11 patients with RA
and 16 patients with OA as controls. After obtaining
written informed consent, a muscle biopsy (approxi-
mately 420 mg) was taken from the distal musculus vas-
tus medialis during elective knee replacement surgery.
Pre-operatively, blood samples were taken for analysis of
C-reactive protein (CRP), using an immunoturbidimetric
method, erythrocyte sedimentation rate (ESR) using the
Westergren method and the number of leucocytes using
flow cytometry. The study was approved by the medical
ethics committee of the Leiden University Medical
Center.
Cell cultures
Myoblast explantation, isolation and cell cultures were
performed as previously described [15-18]. Muscle biop-
sies from the musculus vastus medialis were dissected
from connective tissue and fat, finely minced and then
plated onto non-coated Petri dishes with growth med-
ium consisting of Dulbecco’s modified Eagle medium
(DMEM, 61965, Invitrogen, Carlsbad, CA, USA), 16%
medium 199 (41150, Invitrogen), 20% fetal calf serum
(FCS, 10270, lot 41Q4096K, Invitrogen) and 50 ng/ml
gentamicin (15750, Invitrogen) supplemented with 5 ng/
ml hepatocyte growth factor (PHG0354, Invitrogen).
Once mononucleated cells had migrated out from the
e x p l a n t s ,t h e yw e r er e m o v e df r o mt h ed i s hb yt r y p s i n i -
zation, using 0.05% trypsin-ethylenediaminetetraacetic
acid (trypsin-EDTA, 25300, Invitrogen). Mononucleated
cells were filtered (40 μm) and plated as a mixed culture
in growth medium. At the time of cell isolation, all cell
populations were considered to be at one population
doubling. All cultures were incubated at 37°C in a
humid air atmosphere containing 5% CO2.C e l l
populations were trypsinized when they reached 80% of
confluence. Myogenic purity of the populations was
determined by immunocytochemistry. To improve myo-
genic purity, cell populations were magnetically labelled
by 15 minutes incubation with 20 μl CD56-micro beats
per 10
6 cells (130-050-401, Multenyi Biotec, Paris,
France). Cell populations were washed with buffer con-
sisting of phosphate buffered saline (PBS, 20012, Invitro-
gen), 0.5% FCS and 2 mM EDTA and CD56 cell
selection was carried out using the MiniMACS (Multe-
nyi Biotec). After determination of the myogenic purity,
cell populations were frozen in 90% FCS and 10%
dimethyl sulphoxide hybri-max (D2650, Sigma-Aldrich,
St. Louis, MO, USA) and preserved at -135°C. Only cell
populations with no spontaneous differentiation after
trypsinization (less than 10 myotubes with more than 2
nuclei in a 100 mm petri dish) and myogenic purity
greater than 75% after CD56 cell selection were used for
further analysis. To optimize the comparison of RA and
OA patients, all experiments were performed in a highly
standardized manner in three batches each containing at
least one RA and one OA patient. At the early replica-
tive phase (mean 10.3 (SD 1.7) population doublings
(PDs)), myogenic purity, viability, proliferation index,
colony formation and growth speed was measured. Pro-
tein analysis and telomere length analysis were per-
formed at mean 14.4 (SD 3.1) PDs. Myogenic purity was
again measured at the mid-term replicative phase (mean
24.3 (SD 4.2) PDs) and at the end of life span (maxi-
mum replicative capacity). The experiments were per-
formed and analyzed blinded for patient diagnosis and
age.
Myogenic purity
Myogenic purity of the cell cultures was determined by
immunocytochemistry. Cells were rinsed in PBS, fixed
with ethanol (100%) and incubated for one hour with
monoclonal mouse D33 (M0760, 1/50, Dako, Trappes,
France) as primary antibody specific for desmin, which
is only expressed in myogenic cells. Specific antibody
binding was revealed in fluorescence by Alexa fluor 488
goat anti mouse antibody (1/750, A11029, Molecular
Probes, Eugene, OR, USA) and nuclei were revealed by
Hoechst (1/2500, 33258, Sigma-Aldrich) staining. Myo-
genic purity was calculated as the percentage of desmin
positive cells divided by the total number of nuclei.
Growth characteristics
To measure the proliferation index, cells were cultured
for 48 hours in culture medium supplemented with 10
μg/ml bromodeoxyuridine (BrdU, B5002, Sigma-
Aldrich). Next, the cells were rinsed in PBS and fixed
with ethanol (100%). To render incorporated BrdU
accessible to antibody, fixed cells were treated with 2 M
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neutralized by three 20-minute washes in 50 mM NaCl,
100 mM Tris HCl pH 7.5. Cells were incubated for one
hour with a monoclonal antibody directed against BrdU
(Bu20a, 1/40, M0744, Dako). Specific antibody binding
was revealed in fluorescence by Alexa fluor 488 goat
anti-mouse antibody and nuclei were revealed by
Hoechst staining. The proliferation index was calculated
as the percentage of BrdU positive cells divided by the
total number of nuclei. The proliferation index was
determined in three experimental triplicates counting at
least 500 nuclei in each experiment.
Five hundred myoblasts were seeded on a 100 mm
dish (353003, Becton Dickinson, Le Pont de Claix,
France) and cultured for 14 days in growth medium to
allow the formation of colonies. During this period the
medium was not changed. Next, cells were rinsed in
PBS, fixed with ethanol (100%) and stained overnight
with Giemsa’s azur eosin methylene blue solution
(109204, Merck, Darmstadt, Germany). Colonies were
defined as a cluster of cells containing 16 cells or more.
The total number of colonies formed was counted in
experimental triplicates. The percentage of myogenic
colonies was detected by immunocytochemistry using
desmin (M0760, 1/50, Dako).
Growth speed was calculated by the number of PDs
per day during the early replicative phase. The number
o fP D sa te a c hp a s s a g ew a sc a l c u l a t e da sl o g ( N/n)/log 2
where N is the number of cells counted at the time of
passage and n is the number of cells initially plated.
During long-term culturing, cells were continuously fed
in a standardized manner by seeding 50,000 cells in a
100 mm dish (353003, Becton Dickinson) and serial pas-
saged when they reached 80% confluence until the end
of their replicative lifespan. Cultures were considered to
be senescent when they failed to divide during three
weeks of re-feeding or if the myogenic purity was
decreased to less than 10%.
Fusion index
To induce differentiation of the mononucleated cells
into multinucleated myotubes, cells were densely
seeded in triplicates on a 12-well dish (353043, Becton
Dickinson, 17,000 cells/cm
2). Once confluent, growth
medium was replaced by differentiation medium con-
sisting of DMEM, 10 μg/ml insulin (I550-250 M,
Sigma-Aldrich), 100 μg/ml transferrin (T4382-IG,
Sigma-Aldrich) and 50 ng/ml gentamicin. After 120
hours, cells were rinsed in PBS and fixed with ethanol
(100%). To stain the myotubes, polyclonal mouse
MF20 antibody (1/80, Developmental Studies Hybri-
doma Bank, Iowa City, IA, USA) was used as the pri-
mary antibody and Alexa fluor 488 goat anti mouse as
the secondary antibody (A11029, 1/750, Molecular
Probes). Nuclei were revealed by Hoechst staining. The
fusion index was calculated as the percentage of nuclei
incorporated into myotubes (> 2 nuclei) to the total
number of nuclei. The fusion index was determined in
three experimental triplicates counting at least 500
nuclei in each experiment.
Protein analysis
Cultures were washed in PBS, scraped in 1 ml ice-cold
PBS, centrifuged at 800 rpm for one minute and cell
pellets were stored at -80°C for further analysis. Cell pel-
lets were resuspended in 150 μL of RIPA buffer (150
mM NaCl, 5 mM EDTA, 50 mM HEPES, 0.5% sodium
deoxycholate, 1% NP-40, 0.1% SDS and complete mini-
protease inhibitor) and protein concentration was deter-
mined with the Pierce BCA kit (Thermo Fisher Scienti-
fic, Rockford, IL, USA), using bovine serum albumin as
a standard. Sample buffer (4% SDS, 20% glycerol, 0.2 M
dithioethreitol, 125 mM Tris-HCl, pH 6.8) was added to
aliquots of cell extracts and boiled for five minutes.
Twenty μg of protein were loaded on 12% SDS-polya-
crylamide gels (SDS-PAGE). Following migration, pro-
teins were transferred to nitrocellulose membranes. The
proteins immobilized on the membranes were immedi-
ately blocked for one hour at room temperature with a
solution containing 5% non-fat dry milk in tris buffered
saline containing 0.1% tween 20 (PBT). The blocked
membranes were then incubated with a rabbit polyclo-
nal anti-p16 antibody (1/1000, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA) and mouse monoclonal anti-
beta-tubulin antibody (1/1000, clone TUB 2, T4026,
Sigma-Aldrich) as the primary antibody and anti-rabbit
or anti-mouse peroxidase conjugated antibody (1/40.000,
GE Healthcare, Orsay, France) as the secondary anti-
body. Anti-p16 and anti-tubulin antibodies were visua-
lized using the ECL plus Western Blotting Detection
System (GE Healthcare). For p21, p53, cleaved caspase-3
and hTERT detection, PDVF membranes were stained
for one minute with 0.1% Ponceau (Sigma-Aldrich).
M o u s ea n t i - p 2 1a n t i b o d y( C P 7 4 ,1 / 2 5 0 ,k i n d l yp r o v i d e d
by A.G. Jochemsen of the Department of Molecular Cell
Biology, LUMC), mouse anti-p53 antibody (1/500, Santa
Cruz Biotechnology), rabbit anti-human-cleaved cas-
pase-3 (H269518, 1/250, R&D Systems, Abingdon, UK),
rabbit anti-hTERT (1531-1, 1/500, Epitomics, Burlin-
game, CA, USA) and monoclonal mouse anti-muscle
actin (1/1000, Santa Cruz Biotechnology) were used as
primary antibodies and fluorochrome conjugated goat
anti-mouse or goat anti-rabbit as secondary antibodies
(1/2000, Licor Biosciences, Lincoln, NE, USA). Quantifi-
cation of protein expression was performed using Ima-
geJ http://rsb.info.nih.gov/ij/ with data obtained from
two experiments. Tubulin or Actin signals were used for
normalization.
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Telomere length was measured by flow cytometry using
fluorescence in situ hybridization with fluorescein-con-
jugated peptide nucleic acid (PNA) as the probe (K5327,
Dako) according to the manufacturer’sp r o t o c o l .I n
short, cultured cells were trypsinized, mixed with the
reference cell line (line 1301; Banca Biologica e Cell Fac-
tory, Genoa, Italy), and hybridized with and without
Cy3-labeled peptide nucleic acid probe. After labelling
the cells with propidium iodide (PI) for DNA content,
acquisition was performed using a FacsAria flow cyt-
ometer (Becton Dickinson) equipped with Diva software.
The probe signal was measured in the FL-1 channel and
the propidium iodide signal in the FL-3 channel. Experi-
mental duplicates were performed and results were ana-
lyzed according to the manufacturer’s protocol.
Oxidative stress
Twenty-four hours after seeding, cell cultures were
exposed to a single acute oxidative stress of 250 μM
H2O2 (H-1009, Sigma-Aldrich) diluted in DMEM with
20% medium 199 and 50 ng/ml gentamicin for 60 min-
utes at 37°C. Next, cell cultures were rinsed with PBS
and cultured in growth medium. Control and stressed
cell cultures of three RA and four OA patients followed
the same treatment protocol in triplicates with and
without the addition of H2O2 respectively. During the
early replicative phase (mean 10.3 (SD 1.7) PDs), myo-
genic purity, viability, proliferation index, colony forma-
tion and growth speed were measured. The percentage
of viable cells was determined 24 hours after oxidative
stress by trypan blue (T8154, Sigma-Aldrich) exclusion.
Statistical analysis
Data are presented as mean and standard deviation.
Experimental triplicates or duplicates were averaged for
statistical analysis. A linear regression model was per-
formed with adjustment for age and gender, myogenic
purity, number of PDs and batch. The P-value tested
the null hypothesis that the diagnosis (RA) does not
influence the outcome parameter. All P-values below
0.05 were considered statistically significant.
Results
To investigate the regenerative potential of satellite
cells in chronic inflammation, 11 RA patients were
included in this study together with 16 OA patients as
controls who were all scheduled for elective knee
replacement surgery (Table 1). The mean age of both
groups was 64 years, with more females in the RA
group (91%) compared to the OA group (56%). The
mean disease duration in the RA group was 16 years
(SD 13). Pre-operative blood samples showed a higher
level of inflammatory markers, including a higher CRP,
ESR and leucocyte level compared to the OA group.
During elective knee replacement surgery, a muscle
biopsy (approximately 420 mg) was taken from the dis-
tal musculus vastus medialis. After mononuclear cell
explantation, the mean myogenic purity of the RA
group was 34% (SD 20) with 18% spontaneous differ-
entiation in the cell cultures compared to 46% (SD 26)
mean myogenic purity in the OA group with 19% of
the samples showing spontaneous differentiation. Cell
strains without spontaneous differentiation of satellite
cells and myogenic purity greater than 75% after CD56
cell selection were considered to be sufficiently pure
for further experiments. The resulting experimental
group included four RA and eight OA patients. As
shown in Table 1 this selected study population had
the same distribution in age, gender, disease duration
and inflammatory markers as the total study
population.
Table 1 Characteristics of patients and satellite cell isolation
Total study population Selected study population
RA
N =1 1
OA
N =1 6
RA
N =4
OA
N =8
Age (years) 64 (12) 64 (9) 65 (9) 64 (9)
Gender (% female) 91 56 75 50
Disease duration (years) 16 (13) - 15 (13) -
CRP (mg/L) 12 (11) 2 (3) 10 (7) 2 (3)
ESR (mm) 28 (13) 11 (6) 28 (15) 11 (7)
Leucocytes (*10
9/L) 10.5 (2.5) 7.0 (1.6) 9.7 (1.4) 7.2 (1.6)
Myogenic purity after explantation (% desmin positive cells) 34 (20) 46 (26) 46 (13) 58 (26)
Spontaneous differentiation* (%) 18 19 0 0
Sufficient biopsy quality# (%) 36 50 100 100
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; N, number of subjects; OA, osteoarthritis; RA, rheumatoid arthritis. Values are given as mean (SD) if
not otherwise stated.
CRP and leukocyte data were available for 14 and 10 patients in the OA and RA group respectively. ESR data were available for 7 patients in OA group and 10
patients in the RA group. *Spontaneous differentiation was defined as 10 or more myotubes with more than 2 nuclei in a 100 mm culture dish. #Sufficient
biopsy quality was defined as no spontaneous differentiation and myogenic purity higher than 75% after CD56 cell selection.
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To investigate the influence of chronic inflammation on
human satellite cell regenerative potential, multiple
satellite cell characteristics were measured (Table 2, Fig-
ure 1). During the early replicative phase (mean 10.3
(SD 1.7) PDs) myogenic purity, viability, proliferation
index, mean number of colonies, myogenic colonies,
growth speed and fusion index were not different
between RA and OA patients as was the myogenic pur-
ity at mid-term and at replicative senescence. As
depicted in Figure 2, the growth curves showed no dif-
f e r e n c eb e t w e e nt h eR Ag r o u pw i t ham e a nm a x i m u m
number of 33.4 (SD 9.7) PDs and the OA group with
mean maximum of 27.4 (SD 5.5) PDs. After adjustment
for age, gender, myogenic purity, number of PDs and
batch, none of these parameters were statistically signifi-
cantly different between RA and OA patients (data not
shown).
Senescence-associated proteins apoptosis and telomere
length
To determine whether senescence is induced in satellite
cells, the expression of hTERT, p53, p21 and p16 pro-
teins was determined at the early replicative phase using
a Western blot analysis. Averages of normalized protein
expression did not significantly differ between RA and
OA patients (Table 2, Figure 3). In addition, none of the
samples were positive for cleaved caspase-3 expression.
Furthermore, the mean relative telomere length was not
different between RA and OA patients (Table 2, Figure
4). After adjustment for age, gender, myogenic purity and
batch, the mean relative telomere length was lower in the
RA group compared to the OA group (b = -0.46, 95% CI
-16 to -0.4%, P = 0.04). The other measurements were
not different. The maximum replicative capacity of the
satellite cell strains was not significantly associated with
telomere length (b = 0.60, 95% CI -1.3 to 2.3%, P = 0.48).
Table 2 Characteristics of satellite cell strains obtained from rheumatoid arthritis patients and osteoarthritis patients
Characteristic RA N =4 O AN =8 b 95% CI P-value
Myogenicity (% desmin positive cells)
After explantation 46 (13) 58 (26) -0.35 -51 to 19 0.32
After CD56 selection 87 (5) 95 (3) -0.72 -13 to -2 0.02
After thawing at early replicative phase* 60 (20) 47 (32) -0.57 -209 to 142 0.62
At mid-term replicative phase# 56 (37) 37 (33) -0.02 -49 to 46 0.95
At maximum replicative capacity 47 (43) 38 (30) -0.07 -86 to 77 0.90
After oxidative stress† 21 (12) 16 (10) 0.21 -341 to 349 0.91
Viability (% alive cells)
At early replicative phase* 91 (4) 94 (2) -0.39 -8 to 4 0.33
After oxidative stress† 33 (24) 34 (24) 0.48 -114 to 153 0.31
Growth characteristics*
Proliferation index‡ (% BrdU positive cells) 86 (2) 85 (6) -0.05 -10 to 9 0.89
Colony formation (number) 78 (44) 85 (34) -0.12 -83 to 66 0.78
Myogenic colonies (%) 30 (16) 27 (31) -0.40 -41 to 7 0.14
Growth speed (PD/day) 0.39 (0.10) 0.32 (0.08) 0.310.28 -0.07 to 0.18-5.0 to 13.9 0.290.28
Maximum replicative capacity (PD) 33.4 (9.7) 27.4 (5.5) -0.29 -385 to 359 0.73
Proliferation index after oxidative stress†‡
(% BrdU positive cells)
15 (15) 34 (24)
Fusion index at early replicative phase*§
(% of fused myonuclei)
27 (12) 25 (13) -0.01 -26 to 26 0.99
Normalized protein expression*
p16 103 (15) 140 (63) -0.62 -85 to 7 0.08
p21 27 (4) 27 (5) -0.28 -13 to 8 0.60
p53 67 (12) 62 (8) -0.18 -18 to 11 0.58
hTERT 32 (6) 39 (14) -0.26 -23 to 11 0.39
Relative telomere length*
(% of ref. cell line 1301)
22 (5) 23 (10) -0.46 -16 to -0.4 0.04
N, number of subjects; OA, osteoarthritis; RA, rheumatoid arthritis. Beta (b). 95% confidence interval (CI) and P-value are shown for linear regression model
adjusted for age and gender, myogenic purity, number of PDs, and batch. Values are given as mean (SD) if not otherwise stated. *Early replicative phase: mean
10.3 (SD 1.7) PDs for myogenic purity, viability, growth characteristics and fusion index; mean 14.4 (SD 3.1) PDs for normalized protein expression and relative
telomere length. #Mid-term replicative phase: mean 24.3 (SD 4.2) PDs. †Myogenic purity, viability and proliferation index was measured at early replicative phase,
24 hours after oxidative stress (one hour of 250 μMH 2O2 at 37°C) in four OA and in three RA patients. ‡Proliferation index was determined as the percentage of
bromodeoxyuridine (BrdU) positive cells after 48 hours of culture with BrdU. §Fusion index was determined as the percentage of fused nuclei (> 2 nuclei per
myofiber) in MF20 positive cells.
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To determine whether satellite cells from RA patients
were more susceptible to oxidative stress, we adminis-
tered a single dose of 250 μMH 2O2 for 60 minutes at
37°C to the cell cultures. Twenty-four hours after oxida-
tive stress, the myogenic purity, viability and prolifera-
tion index were decreased in both the RA and OA
group. None of the cell strains were able to reach con-
fluence after three weeks or to form colonies after oxi-
dative stress. The satellite cells from the RA group were
as susceptible to oxidative stress as the OA group as
shown in Table 2, also after adjustment for age, gender,
batch and myogenic purity (data not shown).
Discussion
The regenerative potential of human muscle stem cells
is thought to be influenced by their microenvironment,
including cytokines. To determine the potential deleter-
ious effect of inflammation on the regenerative capacity
of skeletal muscle, we compared muscle biopsies
obtained from patients with chronic inflammation (RA)
to control patients (OA). We found no differences in
myogenic purity, viability, growth speed, differentiation
and maximum proliferative capacity. These results were
Figure 1 In vitro characterization of human satellite cells.R e p r e s e n t a t i v ei m a g e so fin vitro characterization of cultured myoblasts using
immunofluorescence with an antibody against desmin (A and B), BrdU (C) and MF20 (D). Specific antibody labeling was revealed using Alexa
fluor 488 green fluorochrome. Nuclei were visualized with Hoechst (blue). Myogenic purity was determined after explantation (A) and increased
after CD56 selection (B). To determine the proliferation index, cells were cultured for 48 hours in culture medium supplemented with 10 μg/ml
BrdU (C). To determine the fusion index, cells were cultured in differentiation medium for 120 hours (D). Original magnification 100 × (A, B and
C) and 100 × (D).
Figure 2 Growth curve of human satellite cells.G r o w t hc u r v e
from thawing (Day 0) until maximum replicative capacity of human
satellite cell strains from patients suffering from rheumatoid arthritis
(N = 4, black lines) or osteoarthritis (N = 8, gray lines).
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in muscle regeneration, including the expression of pro-
teins involved in replicative and stress induced prema-
ture senescence and apoptosis. Telomere length was
shorter in RA patients compared to controls.
Mechanisms involved in the regenerative potential of
muscle include the ability to restore the quiescent satel-
lite cell pool which has been shown to decrease during
aging by a decrease in the number of satellite cells pre-
sent in muscle biopsies [9,14]. Recently, we have shown
that chronic inflammation does not influence the num-
ber of satellite cells in human muscle (data submitted
for publication). In the present study, we provide new
evidence that the in vitro regenerative potential of
human satellite cells seems not to be affected by chronic
inflammation.
Mechanisms affecting the regenerative potential of
muscle include the number of satellite cells which are
able to proliferate, their growth speed and their maxi-
mum proliferative capacity which have been shown to
be affected by age [8]. In the present study we demon-
strate in vitro, that chronic inflammation in vivo does
neither affect any of the growth characteristics nor the
differentiation potential of human satellite cells. Regen-
erative potential of human satellite cells is limited by
the progressive erosion of their telomeres after each cell
division leading to critically short telomere length and
the activation of replicative senescence through a p53
and p21 dependent pathway [19]. The erosion of telo-
meres can be prevented by the catalytic subunit of the
telomerase (hTERT) leading to extension of replicative
Figure 3 Protein expression of human satellite cells. A:
Representative image of hTERT, p53, p21 and p16 expression in
human satellite cells from patients suffering from rheumatoid
arthritis (N = 4) or osteoarthritis (N = 8). Actin and tubulin
expression was used for normalization. B: Normalized average
protein expression and 95% confidence interval of hTERT, p53, p21
and p16.
Figure 4 Telomere length of human satellite cells. Telomere length was measured by flow cytometry using fluorescence in situ hybridization
without (A) or with the fluorescein-conjugated PNA probe (B). Propidium iodide (PI) was used for labeling DNA content. The telomere probe
signal was measured in the FL-1 channel and the PI signal in the FL-3 channel. G0/1 phase sample and control cells were gated according to
their PI specific signal on a dot blot (FL1-H vs. FL3-H). Relative telomere length (RTL) was calculated by: RTL = (mean FL1 sample cells with
probe - mean FL1 sample cells without probe)/(mean FL1 control cells with probe - mean FL1 control cells without probe) * 2 * 100%.
Representative images are shown of the one of the RA patients. For each sample analyzed 20,000 counts were acquired.
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patients was significantly lower after correction for age,
gender, myogenic purity, batch and number of popula-
tion doublings, which could suggest an increased turn-
over of these cells. However, this difference was
minimal and the expression of p53, p21 and hTERT
proteins were not different between RA and OA
patients. Therefore, we conclude that chronic inflamma-
tion does not significantly increase nuclear turnover
which is in agreement with our findings regarding the
growth characteristics of satellite cells cultures. Stress
induced premature senescence has been shown to be
induced by p16 in aging and myotonic dystrophy. Here
we demonstrate that p16 is not increased in chronic
inflammation [17,21]. Apoptosis and programmed cell
death was not detected during the amplification of
either chronic inflammation (RA) or control cells (OA)
using anti-cleaved caspase 3 [22].
An unexpected finding was the low mean myogenic
purity after explantation in both groups, as myogenic
purity was shown to be high in both young and old age,
which could have been due to the different biopsy mate-
rial and procedures used in the different studies [8]. To
optimize myogenic purity, we performed a CD56 mag-
netic selection procedure and only cell populations with
a mean myogenic purity higher than 75% were included
in our study. Some cell cultures showed spontaneous
differentiation and were, therefore, excluded. Because of
low myogenic purity and increased spontaneous differ-
entiation, we were able to obtain fewer biopsies in the
R Ag r o u pt h a ni nt h eO Ag r o u pf o rin vitro experi-
ments. Although the difference in muscle biopsy quality
was not significant, this could indicate that chronic
inflammation does influence satellite cell behavior and
ultimately the regenerative potential of the muscle.
Non-myogenic stem cells have, however, been shown to
contribute to muscle regeneration [23]. After thawing,
we also observed a decrease in mean myogenic purity in
both groups. Freezing could have led to stress by cold
shock, ice formation, activation of apoptosis mechanisms
and alteration of certain signalling pathways. Fetal and
newborn muscle cells have been shown to conserve
their high myogenic purity after long-term cryopreserva-
tion; however, adult cells are more difficult to explant
and have a lower myogenic purity [24]. In the present
study, we did not observe a correlation between myo-
blast telomere length and replicative capacity. Further-
m o r e ,w ed i dn o to b s e r v eac o r r e l a t i o nb e t w e e n
telomere length and other markers of replicative capa-
city like the expression of p21, p53 or hTERT. A poten-
tial explanation involves the induction of pathways
involved in stress induced senescence, being telomere
length independent, which cannot be excluded during in
vitro replicative senescence [25]. Serial culturing
represents a major difference from the in vivo environ-
ment, including changes in their physical environment,
the cell to cell interaction and different nutrition supply,
which could induce oxidative stress, DNA damage and,
finally, stress induced premature senescence [26,27].
As a model for chronic inflammation, the study included
patients suffering from RA who indeed showed a higher
level of inflammation compared to OA patients as indi-
cated by CRP, ESR and number of leucocytes. Further-
more, the two groups showed the same age distribution.
Although OA is associated with local inflammation [28],
we did not use a healthy control group because such a
control group is physically more active, which would then
possibly confound the results [29]. Furthermore, healthy
patients without an underlying chronic condition are not
available for the same muscle biopsy area, technique and
biopsy size. The strength of this study is the rigorous stan-
dardization in terms of patient selection, muscle biopsy
location, cell culture experiments in batches with both RA
and OA patients and the extensive phenotyping of the
satellite cell populations. The limitations of this study are
that the influence of chronic inflammation on the in vitro
regenerative potential of human satellite cells may not be
found due to the selection of muscle biopsies with good
quality. Secondly, the in vitro experiments might not
reflect the in vivo situation and finally the small number of
included patients made it impossible to differentiate within
and between the groups on the presence of biological
treatment (for example, anti TNF). In addition, it should
be noted that there was a certain selection since the myo-
genic purity was lower in the RA group and many cells
were lost to spontaneous differentiation which could be
due to an increased expression of p16. However, including
more patients was not possible due to the extensive phe-
notyping of each satellite cell strain. Furthermore, the RA
group included more females (75%) compared to the OA
group (50%). Myogenic purity and gender were adjusted
for in the linear regression model and had no effect on
satellite cell regenerative potential in vitro.
Muscle weakness is an increasing clinical problem and
occurs upon injury, neuromuscular diseases and aging,
leading to disability and increased mortality [1-3,30,31].
Stem cell therapy is one possible strategy to regenerate
muscle. Although many studies with different types of
stem cells have been conducted, the efficacy of cell therapy
is still limited by homing and a reduced ability to resist the
environment of the damaged muscle [32]. Conboy et al.
showed that heterochronic parabiosis could restore the
regenerative capacity of aged satellite cells [33]. The circu-
lating factors presented by a shared circulatory system
could be the possible explanation for the observed rejuve-
nation. Therefore, the microenvironment of muscle in
which pro-inflammatory cytokines have been shown to
result in a higher catabolic rate and loss of muscle mass
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of the hallmarks of inflammation is the release of interleu-
kins and tumour necrosis factor-a (TNFa) attracting
macrophages which are critical in the repair of skeletal
muscle by the release of cytokines and growth factors and
by phagocytosis. However, in their attempt to enhance tis-
sue repair they may also destroy surrounding healthy mus-
cle fibers [34]. Furthermore, TNF-a induces activation of
transcription factor NF-B, which results in activation of
the ubiquitin-proteasome pathway and breakdown of
MyoD and myogenin, which are essential regulators for
satellite cell differentiation [35] as well as contractile pro-
teins essential in maintaining muscle mass. Inflammatory
factors could be the cause of lower muscle strength of
patients with RA compared to OA [14].
In vitro, our results demonstrate no difference in
potential regenerative capacity between satellite cells
from patients with chronic inflammation and control
patients. This could be due to the fact that the satellite
cells of both patient groups were put in culture and,
therefore, both experienced an optimized microenviron-
ment for proliferation and differentiation. Consequently,
our results show that there is no difference in satellite
cell behavior in vitro, indicating that circulating inflam-
matory factors in vivo could be the cause of the decrease
in muscle strength. Further evidence of the in vivo influ-
ence of inflammatory cytokines has been shown by anti-
inflammatory treatment, which has been shown to
improve muscle regeneration after injection with
mesoangioblasts [36].
Conclusions
In conclusion, in the present study we found evidence
that chronic inflammation in RA does not affect the in
vitro regenerative potential of human satellite cells. This
result underscores the in vivo influence of inflammatory
factors on muscle regeneration. Identification of mechan-
isms influencing muscle regeneration by modulation of
its microenvironment may improve strategies to regener-
ate human muscle, in particular in conditions such as
muscle injury, neuromuscular disorders and aging.
Key messages
RA does not affect in vitro regenerative potential of
human satellite cells compared to controls.
RA does not affect senescence associated protein
expression in satellite cells compared to controls.
Telomere length in satellite cells from RA patients is
shorter compared to controls.
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